Lena Savoie
Alcoholic hepatitis is an inflammatory condition of the liver caused by excessive alcohol consumption. It is important to determine the presence and severity of alcoholic hepatitis, as it can lead to severe complications and even death if left untreated. Laboratory tests, including white cell counts and platelet counts, play a crucial role in the diagnosis and management of this condition. While a high white cell count is indicative of inflammation, the significance of platelet counts in alcoholic hepatitis is more complex and has been the subject of numerous studies.
| Characteristics | Values |
|---|---|
| Platelet count in alcoholic hepatitis | 178 ± 81 v 98.4 ± 43 (× 109/L) |
| Platelet count in patients without alcoholic hepatitis | 98.4 ± 43 (× 109/L) |
| Cut-off value for platelet count to diagnose alcoholic hepatitis | >147.5 × 109/L |
| Lower boundary of platelet count to rule out alcoholic hepatitis | <86 × 109/L |
| Platelet distribution width (PDW) | 17.10 ± 1.21 |
| Mean platelet volume (MPV) | 5.99 ± 0.96 |
| Plateletcrit (PCT) | 0.14 ± 0.04 |
| Mean AST | 147.49 ± 87.21 |
| Mean ALT | 69.28 ± 49.74 |
| Percentage of patients with thrombocytopenia and chronic liver disease | 76% |
| Average alcohol consumption for alcoholic hepatitis | ∼100 g/day |
Explore related products
What You'll Learn
A high platelet count is a feature of alcoholic hepatitis
Alcoholic hepatitis is an inflammatory condition of the liver that occurs in response to alcohol consumption of approximately 100 g/day. It is characterised by jaundice and deranged liver function tests.
The reason for this difference is thought to be related to the stage of liver disease. Patients with alcoholic hepatitis but without advanced fibrotic liver disease and portal hypertension are more likely to have higher platelet counts. This is because portal hypertension can lead to thrombocytopenia (low platelet count) through reduced platelet production and splenic sequestration. Thrombocytopenia is present in up to 76% of patients with chronic liver disease, and lower platelet counts are associated with more severe portal hypertension.
In addition to platelet count, a high white blood cell count is also a feature of alcoholic hepatitis. This is in keeping with the condition's inflammatory nature.
Platelet indices, such as platelet distribution width (PDW), plateletcrit (PCT), and mean platelet volume (MPV), have been used in the diagnosis and prognosis of various abdominal disorders. However, while they appear to be significantly altered in alcoholic hepatitis, they do not predict severe disease.
Salvaging Your Galaxy S6 After Alcohol Damage
You may want to see also
Explore related products
![14-Parameters Urine Reagent Strips [150ct], Comprehensive Urinalysis Detection with Fast Full Check-up | Kidney, Liver, UTI, Ketosis - CRE, PRO, BIL, KET, SG +9 More](https://m.media-amazon.com/images/I/713gWm-QqbL._AC_UL320_.jpg)
Alcoholic hepatitis is an inflammatory condition
Platelet indices, such as platelet distribution width (PDW), plateletcrit (PCT), and mean platelet volume (MPV), have been used in the diagnosis and prognosis of various abdominal disorders. However, they have not been used to predict the severity of alcoholic hepatitis. While platelet indices appear to be significantly altered in alcoholic hepatitis, they do not seem to be predictors of severe disease.
Thrombocytopenia, or low platelet count, is present in up to 76% of patients with chronic liver disease, and is associated with greater severity of portal hypertension. In patients with alcoholic hepatitis, the platelet count can be affected by the acute effects of alcohol, which can impair platelet production and cause platelet toxicity and accelerated platelet apoptosis. A low platelet count is an important prognostic marker in patients with chronic liver disease.
In a study of 178 patients, the mean MPV was increased in patients with chronic alcohol abuse compared to controls. The MPV/platelet ratio differed significantly between the two groups. Another study found that platelet counts correlated inversely with anti-PAC-1 and anti-CD62P antibodies.
In summary, alcoholic hepatitis is an inflammatory condition associated with higher platelet counts compared to those without the disease. Platelet indices are altered in alcoholic hepatitis, but do not seem to predict disease severity. Thrombocytopenia is common in patients with chronic liver disease and is associated with greater severity of portal hypertension. Platelet counts can be affected by the acute effects of alcohol, and a low platelet count is a prognostic marker in patients with chronic liver disease.
Uber Eats: Opting Out of Alcohol Delivery
You may want to see also
Explore related products
Thrombocytopenia is common in chronic liver disease
Thrombocytopenia, or a low platelet count, is the most common laboratory abnormality observed in patients with chronic liver disease. It is present in up to 76% of patients with chronic liver disease, and lower platelet counts are associated with more severe portal hypertension.
The pathophysiology of thrombocytopenia in chronic liver disease is multifactorial. It includes splenomegaly and subsequent increased sequestration of circulating platelets by the spleen, reduced hepatic synthesis of thrombopoietin (TPO), and increased platelet destruction or consumption. The decrease in thrombopoietin synthesis has been identified as a central mechanism in the development of thrombocytopenia. Thrombopoietin is a key regulator of platelet production, and impaired production can lead to reduced platelet counts.
In patients with alcoholic hepatitis, the platelet count can be further affected by the acute effects of alcohol, including direct impairment of megakaryopoiesis, platelet toxicity, and accelerated platelet apoptosis. A low platelet count is an important prognostic marker in patients with chronic liver disease. It is associated with an increased risk of bleeding, especially during invasive procedures, and can complicate the management of these patients.
Several novel agents have been developed to increase platelet production and reduce the need for platelet transfusions in patients with thrombocytopenia associated with chronic liver disease. These include TPO-receptor agonists such as avatrombopag and lusutrombopag, which have demonstrated efficacy and safety in clinical trials. These advancements may allow patients with chronic liver disease to undergo invasive procedures with reduced risk of bleeding.
Helping Your Son: Alcoholism and Recovery
You may want to see also
Explore related products
Platelet indices are altered in alcoholic hepatitis
Platelet indices are indeed altered in alcoholic hepatitis, but they do not predict severe disease. A retrospective cross-sectional study was conducted at Indira Gandhi Medical College and Research Institute, Pondicherry, to determine whether platelet indices could be used to predict severe alcoholic hepatitis and to compare the platelet indices in patients with and without severe alcoholic hepatitis. The platelet indices used in the study were platelet distribution width (PDW), plateletcrit (PCT), and mean platelet volume (MPV). These indices have been used in the diagnosis and prognosis of various abdominal disorders but have never been used to predict the severity of alcoholic hepatitis.
The study included 119 patients, most of whom were men (115/119). Sixty per cent of the patients presented with abdominal pain, while 36 complained of fever. Hepatomegaly (56) and disorientation (41) were the most common systemic findings. Coexisting illnesses included pancreatitis (14), cirrhosis (19), infections (23), alcohol withdrawal syndrome (103), and anemia (61).
The results of the study showed that platelet indices are significantly altered in alcoholic hepatitis. However, they are not predictive of severe disease. Only bilirubin and prothrombin prolongation were significant predictors of severe alcoholic hepatitis. The area under the curve was highest for PCT at 0.622, but it was not statistically significant (P = .07).
In conclusion, platelet indices are altered in alcoholic hepatitis, but they do not appear to be useful in predicting the severity of the disease. Further research is needed to determine whether the inability to predict severe alcoholic hepatitis is due to coexisting illnesses.
Similarities Between Alcoholics and Necrophiliacs: A Dark Comparison
You may want to see also
Explore related products
Alcohol inhibits platelet aggregation
Alcoholic hepatitis is an inflammatory condition that affects the liver. It is characterised by a high white blood cell count and, interestingly, a high platelet count. Thrombocytopenia, or a low platelet count, is present in up to 76% of patients with chronic liver disease, and is associated with greater severity of portal hypertension. However, in the case of alcoholic hepatitis, the platelet count is higher than in those without alcoholic hepatitis. This is likely because patients without alcoholic hepatitis have more advanced fibrotic liver disease with portal hypertension leading to decompensation.
Several studies in humans and animals have shown that the immediate effect of alcohol consumption is to decrease platelet aggregation in response to most agonists, including thrombin, ADP, epinephrine, and collagen. This is similar to the effect of aspirin. In fact, moderate alcohol consumption has been shown to protect against morbidity and mortality from coronary heart disease and ischemic stroke. However, alcohol consumption may also predispose individuals to cerebral haemorrhage.
The effect of alcohol on platelet aggregation is dose-dependent, with heavy alcohol consumption inhibiting platelet function and aggregation to various agonists. In the case of binge drinking or alcohol withdrawal, the response to aggregation, especially that induced by thrombin, is markedly increased. This is due to increased levels of TxA2 and hyperaggregability, which are thought to cause an increase in ischaemic stroke.
In summary, while alcoholic hepatitis is associated with a high platelet count, alcohol consumption has been shown to inhibit platelet aggregation. This effect is most pronounced in heavy drinkers, and may be one of the mechanisms by which alcohol predisposes individuals to cerebral haemorrhage.
Nighttime alcohol sales: a recipe for disaster
You may want to see also
Frequently asked questions
A high platelet count, or thrombocytopenia, is present in up to 76% of patients with chronic liver disease and is a common laboratory abnormality in patients with alcoholic hepatitis. It is often associated with more advanced fibrotic liver disease with portal hypertension leading to decompensation.
A platelet count of >147.5 x 109/L can be used to accurately diagnose alcoholic hepatitis with 100% specificity.
Platelet distribution width (PDW), plateletcrit (PCT), and mean platelet volume (MPV) are commonly used platelet indices in the prognosis of alcoholic hepatitis. Higher platelet counts are associated with greater white blood cell counts, absolute neutrophil counts, and higher Na-MELD scores.
White blood cell count and platelet count are both associated with histological alcoholic hepatitis in jaundiced harmful drinkers. A high white blood cell count is indicative of an inflammatory condition, which is consistent with alcoholic hepatitis.
Alcohol has an inhibitory effect on platelet aggregation and can also enhance platelet activation. Ethanol can directly impair megakaryopoiesis, cause platelet toxicity, and accelerate platelet apoptosis.
